Chelsea Therapeutics International, Ltd.
DelistedCIK 1333763fmd_0RCAWRZK63CVER9W73PGBJHSNYManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2004 to Mar 31, 2014, 22 periods
| Line item | FY2004 | FY2005 | FY2006 | FY2007 | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | – | – | – | 1 | – | 24 | 31 | 37 | 17 | 10 |
| Selling, general and administrative | – | – | – | – | – | 6 | 7 | 13 | 13 | 6 |
| Total operating expenses | – | – | – | – | – | 30 | 38 | 51 | 32 | 16 |
| Operating income | – | – | – | – | – | (30) | (38) | (51) | (32) | (16) |
| Interest expense | – | – | – | – | – | 0 | 0 | 0 | 0 | 0 |
| Interest and investment income | – | – | – | – | – | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | – | – | – | – | – | 4 | – | – | – | – |
| Net income | (3) | (8) | (9) | (15) | (35) | (26) | (37) | (50) | (32) | (16) |